• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
  

PubMed=2441858
Lloyd R. Kelland, Lynne Burgess, George Gordon Steel;
Characterization of four new cell lines derived from human squamous carcinomas of the uterine cervix.
Cancer Res. 47:4947-4952(1987)

PubMed=2475347; DOI=10.1016/0277-5379(89)90417-3
Lloyd R. Kelland, Katia S. Tonkin;
In vitro chemosensitivity of four new carcinoma of the cervix cell lines: relationship to radiosensitivity.
Eur. J. Cancer Clin. Oncol. 25:1211-1218(1989)

PubMed=2813837; DOI=10.1016/0167-8140(89)90070-4
Katia S. Tonkin, Lloyd R. Kelland, George Gordon Steel;
A comparison of the in vivo and in vitro radiation response of three human cervix carcinomas.
Radiother. Oncol. 16:55-63(1989)

PubMed=8347478; DOI=10.1038/bjc.1993.322; PMCID=PMC1968570
Kirste J. Mellish, Lloyd R. Kelland, Kenneth Reginald Harrap;
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
Br. J. Cancer 68:240-250(1993)

PubMed=7751322; DOI=10.1007/BF01366967
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Reidar Grenman;
The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.
J. Cancer Res. Clin. Oncol. 121:230-234(1995)

PubMed=9887230; DOI=10.1006/gyno.1998.5194
Virpi Rantanen, Seija E. Grenman, Kaisa Kurvinen, Sakari H. Hietanen, Misa Raitanen, Stina M. Syrjanen;
p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Gynecol. Oncol. 71:352-358(1998)

PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225
Ma de Lourdes Zuniga-Martinez, Carlos Miguel Lopez-Mendoza, Jared Tenorio-Salazar, Alejandro Manuel Garcia-Carranca, Marco Antonio Cerbon-Cervantes, Luz Eugenia Alcantara-Quintana;
Establishment, authenticity, and characterization of cervical cancer cell lines.
Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022)